Report date: Apr 30, 2024
Conflict count: 350192
Publisher: University of Minnesota
Title count: 4
Conflict count: 28


==========================================================

Created: 2021-02-23 12:10:38.0
ConfID: 5956894
CauseID: 1490229362
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Isetts, 8 ,1,null,2017,An Evaluation of the Distribution, Scope, and Impact of Community Pharmacy Foundation Grants Completed by Academic Principal Investigators between 2002 and 2014
DOI: 10.24926/21550417.1332(Journal) (5956894-N )
DOI: 10.24926/iip.v8i1.504(Journal)
==========================================================

Created: 2021-02-23 12:10:41.0
ConfID: 5956895
CauseID: 1490229374
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Wilby, 8 ,1,null,2017,A Standardized Narrative Profile Approach to Self-Reflection and Assessment of Cross-Cultural Communication
DOI: 10.24926/21550417.1313(Journal) (5956895-N )
DOI: 10.24926/iip.v8i1.503(Journal)
==========================================================

Created: 2021-02-23 12:10:43.0
ConfID: 5956896
CauseID: 1490229377
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Langley, 8 ,1,null,2017,Intelligent Design and Imaginary Worlds in Cost-Effectiveness Claims: An Overview of Commentaries in INNOVATIONS in Pharmacy from July 2016 to February 2017
DOI: 10.24926/21550417.1368(Journal) (5956896-N )
DOI: 10.24926/iip.v8i1.502(Journal)
==========================================================

Created: 2021-02-23 12:10:48.0
ConfID: 5956897
CauseID: 1490229394
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Hwang, 8 ,1,null,2017,Exploring Strategies to Enhance the Presentation of Information in Print DTCA to Improve Consumers’ Recall of Information
DOI: 10.24926/21550417.1355(Journal) (5956897-N )
DOI: 10.24926/iip.v8i1.501(Journal)
==========================================================

Created: 2021-02-23 12:10:53.0
ConfID: 5956898
CauseID: 1490229409
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Anthony, 8 ,1,null,2017,Geographic Distribution of Antipsychotic Use in Medicare Part D Patients
DOI: 10.24926/21550417.1345(Journal) (5956898-N )
DOI: 10.24926/iip.v8i1.499(Journal)
==========================================================

Created: 2021-02-23 12:10:55.0
ConfID: 5956899
CauseID: 1490229420
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Amin, 8 ,1,null,2017,Injudicious Provision of Subtherapeutic Doses of Antibiotics in Community Pharmacies
DOI: 10.24926/21550417.1352(Journal) (5956899-N )
DOI: 10.24926/iip.v8i1.498(Journal)
==========================================================

Created: 2021-02-23 12:10:57.0
ConfID: 5956900
CauseID: 1490229427
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Taylor, 8 ,1,null,2017,Patient Feedback on Pharmacist Prescribing for Minor Ailments in a Canadian Province
DOI: 10.24926/21550417.1331(Journal) (5956900-N )
DOI: 10.24926/iip.v8i1.497(Journal)
==========================================================

Created: 2021-02-23 12:10:59.0
ConfID: 5956901
CauseID: 1490229428
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Kowalski, 8 ,1,null,2017,Characteristics of Patients Accepting and Declining Participation in a Transition of Care Service Provided by a Community Pharmacy
DOI: 10.24926/21550417.1310(Journal) (5956901-N )
DOI: 10.24926/iip.v8i1.496(Journal)
==========================================================

Created: 2021-02-23 12:11:01.0
ConfID: 5956902
CauseID: 1490229441
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Hixon, 8 ,1,null,2017,Level of Evidence Associated with FDA Safety Communications with Drug Labeling Changes: 2010-2014
DOI: 10.24926/21550417.1347(Journal) (5956902-N )
DOI: 10.24926/iip.v8i1.495(Journal)
==========================================================

Created: 2021-02-23 12:11:03.0
ConfID: 5956903
CauseID: 1490229442
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Twigg, 8 ,1,null,2017,Interprofessional Approach to Increase Billable Care-Events in a Rural Community
DOI: 10.24926/21550417.1342(Journal) (5956903-N )
DOI: 10.24926/iip.v8i1.494(Journal)
==========================================================

Created: 2021-02-23 12:11:05.0
ConfID: 5956904
CauseID: 1490229449
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Langley, 8 ,1,null,2017,Imaginary Worlds and Efficiency Frontiers: Should We Abandon the IQWiG Health Technology Assessment Model?
DOI: 10.24926/21550417.1362(Journal) (5956904-N )
DOI: 10.24926/iip.v8i1.493(Journal)
==========================================================

Created: 2021-02-23 12:11:07.0
ConfID: 5956905
CauseID: 1490229456
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Langley, 8 ,1,null,2017,Multiple Sclerosis and the Comparative Value Disease Modifying Therapy Report of the Institute for Clinical and Economic Review (ICER)
DOI: 10.24926/21550417.1358(Journal) (5956905-N )
DOI: 10.24926/iip.v8i1.492(Journal)
==========================================================

Created: 2021-02-23 12:11:10.0
ConfID: 5956906
CauseID: 1490229458
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: DiPietro Mager, 8 ,1,null,2017,Opportunities for Pharmacists and Student Pharmacists to Provide Clinical Preventive Services
DOI: 10.24926/21550417.1340(Journal) (5956906-N )
DOI: 10.24926/iip.v8i1.491(Journal)
==========================================================

Created: 2021-02-23 12:11:12.0
ConfID: 5956907
CauseID: 1490229472
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Costelloe, 8 ,1,null,2017,MyDispense: Lessons from Global Collaboration in Developing a Pharmacy Educational Simulation Tool
DOI: 10.24926/21550417.1356(Journal) (5956907-N )
DOI: 10.24926/iip.v8i1.490(Journal)
==========================================================

Created: 2021-02-23 12:11:14.0
ConfID: 5956908
CauseID: 1490229473
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Baki, 8 ,1,null,2017,Introducing an Undergraduate Degree of Cosmetic Science and Formulation Design within a College of Pharmacy
DOI: 10.24926/21550417.1308(Journal) (5956908-N )
DOI: 10.24926/iip.v8i1.489(Journal)
==========================================================

Created: 2021-02-23 12:11:16.0
ConfID: 5956909
CauseID: 1490229484
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Langley, 8 ,1,null,2017,HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
DOI: 10.24926/21550417.1351(Journal) (5956909-N )
DOI: 10.24926/iip.v8i1.488(Journal)
==========================================================

Created: 2021-02-23 12:11:21.0
ConfID: 5956910
CauseID: 1490229500
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Schommer, 8 ,1,null,2017,Applying Personality Type Theory to Develop Individualized Wellness Plans for Reducing Chronic Diseases
DOI: 10.24926/21550417.1328(Journal) (5956910-N )
DOI: 10.24926/iip.v8i1.487(Journal)
==========================================================

Created: 2021-02-23 12:11:23.0
ConfID: 5956911
CauseID: 1490229501
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Rowles, 8 ,1,null,2017,Performance on Interdisciplinary Topics in an Integrated Pharmacy Course
DOI: 10.24926/21550417.1298(Journal) (5956911-N )
DOI: 10.24926/iip.v8i1.486(Journal)
==========================================================

Created: 2021-02-23 12:11:25.0
ConfID: 5956912
CauseID: 1490229515
OtherID: 1419805895
JT: INNOVATIONS in pharmacy
MD: Langley, 8 ,1,null,2017,Dreamtime: Version 5.0 of the Australian Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)
DOI: 10.24926/21550417.1346(Journal) (5956912-N )
DOI: 10.24926/iip.v8i1.485(Journal)